BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 27573781)

  • 1. Histopathological, Molecular, and Genetic Profile of Hereditary Diffuse Gastric Cancer: Current Knowledge and Challenges for the Future.
    van der Post RS; Gullo I; Oliveira C; Tang LH; Grabsch HI; O'Donovan M; Fitzgerald RC; van Krieken H; Carneiro F
    Adv Exp Med Biol; 2016; 908():371-91. PubMed ID: 27573781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histopathologic Analysis of Signet-ring Cell Carcinoma In Situ in Patients With Hereditary Diffuse Gastric Cancer.
    Tsugeno Y; Nakano K; Nakajima T; Namikawa K; Takamatsu M; Yamamoto N; Fujisaki J; Nunobe S; Kitagawa M; Takeuchi K; Kawachi H
    Am J Surg Pathol; 2020 Sep; 44(9):1204-1212. PubMed ID: 32520759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histologic and immunohistochemical differences between hereditary and sporadic diffuse gastric carcinoma.
    Lee HE; Smyrk TC; Zhang L
    Hum Pathol; 2018 Apr; 74():64-72. PubMed ID: 29307626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1): pathologic findings with clinical implications.
    Rogers WM; Dobo E; Norton JA; Van Dam J; Jeffrey RB; Huntsman DG; Kingham K; Chun N; Ford JM; Longacre TA
    Am J Surg Pathol; 2008 Jun; 32(6):799-809. PubMed ID: 18391748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.
    van der Post RS; Vogelaar IP; Manders P; van der Kolk LE; Cats A; van Hest LP; Sijmons R; Aalfs CM; Ausems MG; Gómez García EB; Wagner A; Hes FJ; Arts N; Mensenkamp AR; van Krieken JH; Hoogerbrugge N; Ligtenberg MJ
    Gastroenterology; 2015 Oct; 149(4):897-906.e19. PubMed ID: 26072394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of pathology in the identification of hereditary diffuse gastric cancer: report of a Portuguese family.
    Oliveira C; Moreira H; Seruca R; de Oliveira MC; Carneiro F
    Virchows Arch; 2005 Feb; 446(2):181-4. PubMed ID: 15735979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic heterogeneity of hereditary diffuse gastric cancer: report of a family with early-onset disease.
    Gullo I; Devezas V; Baptista M; Garrido L; Castedo S; Morais R; Wen X; Rios E; Pinheiro J; Pinto-Ribeiro I; Ferreira RM; Preto J; Santos-Antunes J; Marques M; Campos M; Almeida F; Espinheira MDC; Amil Dias J; Figueiredo C; Oliveira C; Trindade E; Carneiro F
    Gastrointest Endosc; 2018 Jun; 87(6):1566-1575. PubMed ID: 29454568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening.
    Carneiro F; Huntsman DG; Smyrk TC; Owen DA; Seruca R; Pharoah P; Caldas C; Sobrinho-Simões M
    J Pathol; 2004 Jun; 203(2):681-7. PubMed ID: 15141383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptomic profiling and quantitative high-throughput (qHTS) drug screening of CDH1 deficient hereditary diffuse gastric cancer (HDGC) cells identify treatment leads for familial gastric cancer.
    Chen I; Mathews-Greiner L; Li D; Abisoye-Ogunniyan A; Ray S; Bian Y; Shukla V; Zhang X; Guha R; Thomas C; Gryder B; Zacharia A; Beane JD; Ravichandran S; Ferrer M; Rudloff U
    J Transl Med; 2017 May; 15(1):92. PubMed ID: 28460635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histopathological and molecular analysis of gastrectomy specimens from hereditary diffuse gastric cancer patients has implications for endoscopic surveillance of individuals at risk.
    Barber ME; Save V; Carneiro F; Dwerryhouse S; Lao-Sirieix P; Hardwick RH; Caldas C; Fitzgerald RC
    J Pathol; 2008 Nov; 216(3):286-94. PubMed ID: 18825658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hereditary Diffuse Gastric Cancer Syndrome: CDH1 Mutations and Beyond.
    Hansford S; Kaurah P; Li-Chang H; Woo M; Senz J; Pinheiro H; Schrader KA; Schaeffer DF; Shumansky K; Zogopoulos G; Santos TA; Claro I; Carvalho J; Nielsen C; Padilla S; Lum A; Talhouk A; Baker-Lange K; Richardson S; Lewis I; Lindor NM; Pennell E; MacMillan A; Fernandez B; Keller G; Lynch H; Shah SP; Guilford P; Gallinger S; Corso G; Roviello F; Caldas C; Oliveira C; Pharoah PD; Huntsman DG
    JAMA Oncol; 2015 Apr; 1(1):23-32. PubMed ID: 26182300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An α-E-catenin (CTNNA1) mutation in hereditary diffuse gastric cancer.
    Majewski IJ; Kluijt I; Cats A; Scerri TS; de Jong D; Kluin RJ; Hansford S; Hogervorst FB; Bosma AJ; Hofland I; Winter M; Huntsman D; Jonkers J; Bahlo M; Bernards R
    J Pathol; 2013 Mar; 229(4):621-9. PubMed ID: 23208944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastric cancer: new genetic developments.
    Lynch HT; Grady W; Suriano G; Huntsman D
    J Surg Oncol; 2005 Jun; 90(3):114-33; discussion 133. PubMed ID: 15895459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic analysis of a case of Helicobacter pylori-uninfected intramucosal gastric cancer in a family with hereditary diffuse gastric cancer.
    Funakoshi T; Miyamoto S; Kakiuchi N; Nikaido M; Setoyama T; Yokoyama A; Horimatsu T; Yamada A; Torishima M; Kosugi S; Yamada H; Sugimura H; Haga H; Sakai Y; Ogawa S; Seno H; Muto M; Chiba T
    Gastric Cancer; 2019 Jul; 22(4):892-898. PubMed ID: 30542785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathological features of total gastrectomy specimens from asymptomatic hereditary diffuse gastric cancer patients and implications for clinical management.
    Rocha JP; Gullo I; Wen X; Devezas V; Baptista M; Oliveira C; Carneiro F
    Histopathology; 2018 Dec; 73(6):878-886. PubMed ID: 30014492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [From gene to disease; E-cadherin and hereditary diffuse gastric cancer].
    de Bruin JH; Ligtenberg MJ; Nagengast FM; van Krieken JH
    Ned Tijdschr Geneeskd; 2003 Dec; 147(50):2474-7. PubMed ID: 14708213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer predisposition and germline CTNNA1 variants.
    Lobo S; Benusiglio PR; Coulet F; Boussemart L; Golmard L; Spier I; Hüneburg R; Aretz S; Colas C; Oliveira C
    Eur J Med Genet; 2021 Oct; 64(10):104316. PubMed ID: 34425242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hereditary diffuse gastric cancer: a manifestation of lost cell polarity.
    Humar B; Guilford P
    Cancer Sci; 2009 Jul; 100(7):1151-7. PubMed ID: 19432899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germline mutation of the E-cadherin gene in three sibling cases with advanced gastric cancer: clinical consequences for the other family members.
    Mayrbaeurl B; Keller G; Schauer W; Burgstaller S; Czompo M; Hoebling W; Knoflach P; Duba HC; Hoefler H; Thaler J
    Eur J Gastroenterol Hepatol; 2010 Mar; 22(3):306-10. PubMed ID: 19474748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E-Cadherin (CDH1) and p53 rather than SMAD4 and Caspase-10 germline mutations contribute to genetic predisposition in Portuguese gastric cancer patients.
    Oliveira C; Ferreira P; Nabais S; Campos L; Ferreira A; Cirnes L; Alves CC; Veiga I; Fragoso M; Regateiro F; Dias LM; Moreira H; Suriano G; Machado JC; Lopes C; Castedo S; Carneiro F; Seruca R
    Eur J Cancer; 2004 Aug; 40(12):1897-903. PubMed ID: 15288293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.